Literature DB >> 14720134

A comprehensive strategy for the interpretation of quality-of-life data based on existing methods.

Patrick Marquis1, Olivier Chassany, Linda Abetz.   

Abstract

OBJECTIVES: Health-related quality of life (HRQL) instruments generally undergo a rigorous development and validation process. In contrast, methods for interpreting HRQL data are varied, and no comprehensive widely applicable procedure exists. Determining whether differences are statistically significant is the most common method, but this yields conclusions that may be difficult to understand in a clinical context or which may be of no practical value. Consequently, there is a need for a comprehensive interpretation strategy that gives results that are meaningful to a variety of audiences, including patients, clinicians, and decision-makers.
METHODS: The review of available interpretation strategies revealed that not all methods are applicable to all questionnaires, and some strategies may be difficult to implement for interpreting trial results. In addition, the issues decision-makers may have when assessing HRQL results have not really been addressed: what is measured and what is the meaning beyond statistical significance?
RESULTS: A comprehensive stepwise strategy, based on the most effective methods available, has been developed to address the key interpretation issues of decision-makers. It is structured around several steps: understanding the content of the questionnaire; evaluating the magnitude of changes and their statistical significance; determining whether results are clinically significant, e.g., whether the observed changes crossed ranges of established threshold for meaningful differences; comparing pre- and post-treatment scores distribution with norms of references; and relating score changes to other outcomes end points such as morbidity, death, compliance, resource utilization, or productivity.
CONCLUSIONS: The proposed strategy should help to structure and successfully address interpretation issues and thus make HRQL results more convincing.

Entities:  

Mesh:

Year:  2004        PMID: 14720134     DOI: 10.1111/j.1524-4733.2004.71217.x

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  12 in total

1.  Health-related quality of life as an outcome variable in Parkinson's disease.

Authors:  Pablo Martinez-Martin; Mónica M Kurtis
Journal:  Ther Adv Neurol Disord       Date:  2012-03       Impact factor: 6.570

2.  Health-related quality of life (HRQL) in immunodeficient adults with selective IgA deficiency compared with age- and gender-matched controls and identification of risk factors for poor HRQL.

Authors:  G H Jörgensen; A Gardulf; M I Sigurdsson; S Arnlaugsson; L Hammarström; B R Ludviksson
Journal:  Qual Life Res       Date:  2014-03       Impact factor: 4.147

Review 3.  Patient-reported assessments in diabetes care: clinical and research applications.

Authors:  Soren E Skovlund
Journal:  Curr Diab Rep       Date:  2005-04       Impact factor: 4.810

4.  Smartphone App for monitoring Asthma in children and adolescents.

Authors:  K Mayoral; O Garin; M A Caballero-Rabasco; M Praena-Crespo; A Bercedo; G Hernandez; J Castillo; C Lizano Barrantes; Y Pardo; M Ferrer
Journal:  Qual Life Res       Date:  2021-01-02       Impact factor: 4.147

5.  The Orthostatic Hypotension Questionnaire (OHQ): validation of a novel symptom assessment scale.

Authors:  Horacio Kaufmann; Richard Malamut; Lucy Norcliffe-Kaufmann; Kathleen Rosa; Roy Freeman
Journal:  Clin Auton Res       Date:  2011-11-02       Impact factor: 4.435

6.  Statistical controversies in cancer research: using standardized effect size graphs to enhance interpretability of cancer-related clinical trials with patient-reported outcomes.

Authors:  M L Bell; M H Fiero; H M Dhillon; V J Bray; J L Vardy
Journal:  Ann Oncol       Date:  2017-08-01       Impact factor: 32.976

Review 7.  Postoperative health-related quality of life of patients with gynecological malignancy: a meta-analysis.

Authors:  Se-Ge Ma; Xue Deng; Lu Xing; Yan Huang
Journal:  Support Care Cancer       Date:  2021-02-17       Impact factor: 3.603

Review 8.  Conceptual and Analytical Considerations toward the Use of Patient-Reported Outcomes in Personalized Medicine.

Authors:  Demissie Alemayehu; Joseph C Cappelleri
Journal:  Am Health Drug Benefits       Date:  2012-07

9.  Fear of hypoglycaemia: defining a minimum clinically important difference in patients with type 2 diabetes.

Authors:  Tom Stargardt; Linda Gonder-Frederick; Karl J Krobot; Charles M Alexander
Journal:  Health Qual Life Outcomes       Date:  2009-10-22       Impact factor: 3.186

10.  Validation of the Fatigue Severity Scale in chronic hepatitis C.

Authors:  Kathleen Rosa; Min Fu; Leen Gilles; Karin Cerri; Monika Peeters; Jeffrey Bubb; Jane Scott
Journal:  Health Qual Life Outcomes       Date:  2014-06-11       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.